138 related articles for article (PubMed ID: 35258368)
1. Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer.
Wu D; Jiang K; Li H; Zhang Z; Ba R; Zhang Y; Hsu YC; Sun Y; Zhang YD
Radiology; 2022 Jun; 303(3):578-587. PubMed ID: 35258368
[TBL] [Abstract][Full Text] [Related]
2. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
[TBL] [Abstract][Full Text] [Related]
3. Histological and molecular classifications of pediatric glioma with time-dependent diffusion MRI-based microstructural mapping.
Zhang H; Liu K; Ba R; Zhang Z; Zhang Y; Chen Y; Gu W; Shen Z; Shu Q; Fu J; Wu D
Neuro Oncol; 2023 Jun; 25(6):1146-1156. PubMed ID: 36617263
[TBL] [Abstract][Full Text] [Related]
4. Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
Zhang Z; Wu HH; Priester A; Magyar C; Afshari Mirak S; Shakeri S; Mohammadian Bajgiran A; Hosseiny M; Azadikhah A; Sung K; Reiter RE; Sisk AE; Raman S; Enzmann DR
Radiology; 2020 Aug; 296(2):348-355. PubMed ID: 32515678
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
6. Performance of Diffusion Kurtosis Imaging Versus Diffusion Tensor Imaging in Discriminating Between Benign Tissue, Low and High Gleason Grade Prostate Cancer.
Di Trani MG; Nezzo M; Caporale AS; De Feo R; Miano R; Mauriello A; Bove P; Manenti G; Capuani S
Acad Radiol; 2019 Oct; 26(10):1328-1337. PubMed ID: 30545680
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-time dependent diffusion MRI: effect of diffusion-time on microstructural mapping and prediction of prognostic features in breast cancer.
Ba R; Wang X; Zhang Z; Li Q; Sun Y; Zhang J; Wu D
Eur Radiol; 2023 Sep; 33(9):6226-6237. PubMed ID: 37071169
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
[TBL] [Abstract][Full Text] [Related]
9. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
11. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
[TBL] [Abstract][Full Text] [Related]
12. Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness.
Hectors SJ; Said D; Gnerre J; Tewari A; Taouli B
J Magn Reson Imaging; 2020 Jul; 52(1):271-279. PubMed ID: 31961049
[TBL] [Abstract][Full Text] [Related]
13. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
[No Abstract] [Full Text] [Related]
14. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
15. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
16. Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer.
Wang Q; Li H; Yan X; Wu CJ; Liu XS; Shi HB; Zhang YD
Urol Oncol; 2015 Aug; 33(8):337.e15-24. PubMed ID: 26048104
[TBL] [Abstract][Full Text] [Related]
17. A valuable MRI examination method for prostate cancer screening.
Yang X; Shan L; Cao H; Jiang X; Ma X
Medicine (Baltimore); 2020 Nov; 99(48):e23134. PubMed ID: 33235074
[TBL] [Abstract][Full Text] [Related]
18. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
[TBL] [Abstract][Full Text] [Related]
19. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]